Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015812 |
---|---|
Receipt number | R000018397 |
Scientific Title | Phase I/II study of HB-EGF-specific inhibitor BK-UM plus weekly paclitaxel therapy in gastric cancer with peritoneal metastasis after failure of first line treatment. |
Date of disclosure of the study information | 2015/01/15 |
Last modified on | 2016/04/13 21:30:48 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/12/01 16:37:00 | ||
2 | Update | 2014/12/01 19:25:48 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
3 | Update | 2015/03/09 10:06:37 | UMIN ID1 |
|
4 | Update | 2015/03/19 19:15:39 | Recruitment status Anticipated trial start date |
|
5 | Update | 2015/05/07 17:30:04 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Institute Institute Email1 |
|
6 | Update | 2015/05/07 17:39:40 | Last name of contact person Email1 |
|
7 | Update | 2015/05/07 17:40:28 | Last name of contact person |
|
8 | Update | 2015/12/07 11:14:41 | Recruitment status |
|
9 | Update | 2016/04/13 21:30:48 | Recruitment status |